EQT agrees to all‑cash takeover of Qiagen at €46.50 per share
+2 new sources since this summary was written
Swedish private‑equity firm EQT announced a binding offer of €46.50 per share for Qiagen, valuing the company at about €9.6 billion in equity and roughly €10.8 billion including debt. Qiagen’s supervisory and managing boards unanimously approved the transaction, which will be funded by equity and debt and is expected to close in mid‑2027. The offer represents a premium of roughly 40 % over the July 8, 2026 closing price of €33.15, and the shares rose about 0.7 % after the announcement.
Why it matters
The cash offer provides shareholders with an immediate premium payout and will result in Qiagen’s delisting from the NYSE and Frankfurt exchanges, changing the company’s capital structure and liquidity profile. The board’s approval signals that the transaction is likely to proceed, subject to regulatory clearance.
Key facts
- 1EQT offered €46.50 per share for Qiagen, valuing the equity at approximately €9.6 billion. globalbankingandfinance.com
- 2Including about $1.1 billion of net debt, the enterprise value of the deal is roughly $12.1 billion. globalbankingandfinance.com
- 3The offer price is about 40.3 % higher than Qiagen’s closing price of €33.15 on July 8, 2026. investing.com
- 4Qiagen’s supervisory and managing boards unanimously approved the transaction. globalbankingandfinance.com
- 5The transaction is expected to close in mid‑2027, pending customary regulatory approvals. globalbankingandfinance.com
- 6Qiagen’s US‑listed shares rose roughly 0.7 % in extended trading after the announcement. globalbankingandfinance.com
Summary written by AlphAI AI Desk from 20 of 29 sources. Not investment advice. Figures are as stated by the linked sources.